DPP4 and Peritoneal Fibrosis: In mice suffering from peritoneal fibrosis induced by MGO, administration of ligagliptin, which is a dipeptidyl peptidase-4 (DPP-4) inhibitor, blocked the infiltration of F4/80-positive macrophages and collagen deposition while improving peritoneal function (160).